Glenfarclas 21
Selected indexed studies
- miR-21 in Human Cardiomyopathies. (Front Cardiovasc Med, 2021) [PMID:34778418]
- The effects of interleukin-21 in the biology of transplant rejection. (Front Immunol, 2025) [PMID:40376002]
- IL-21 Signaling in Immunity. (F1000Res, 2016) [PMID:26966515]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- miR-21 in Human Cardiomyopathies. (2021) pubmed
- The effects of interleukin-21 in the biology of transplant rejection. (2025) pubmed
- IL-21 Signaling in Immunity. (2016) pubmed
- Therapeutic potential of interleukin-21 in cancer. (2024) pubmed
- Interleukin-21 in chronic inflammatory diseases. (2013) pubmed
- Clinical significance and immunobiology of IL-21 in autoimmunity. (2019) pubmed
- IL-21 and IL-21 receptor in the immunopathogenesis of multiple sclerosis. (2016) pubmed
- MicroRNA-21 Silencing in Diabetic Nephropathy: Insights on Therapeutic Strategies. (2023) pubmed
- miR-21-5p prevents doxorubicin-induced cardiomyopathy by downregulating BTG2. (2023) pubmed
- MicroRNA-21 and its impact on signaling pathways in cervical cancer. (2019) pubmed